Gaucher's Disease Flashcards

1
Q

What is Gaucher’s disease?

A

Lysosomal storage disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are some functions of the lysosome?

A

Exocytosis: secretion of proteins from the ER and golgi

Exocytosis: discharge of undegraded residual material from a secondary lysosome

Endocytosis: fusion with endosome carrying contents from the extracellular environment

Phagocytosis: fusion with phagosome carrying contents from extracellular environment. Phagosomes are larger than endosomes and carry larger structures like microbes

Autophagy: degradation of cellular debris

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What enzyme is defective in Gaucher’s disease and what reaction does it catalyze?

A

Acid B-glucosidase (glucocerebrosidase) is a lysosomal enzyme that catalyzes hydrolysis of the sphingolipid glucocerebroside (aka glucosylceramide) into glucose and ceramide.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Where does glucocerebroside come from?

A

Component of the plasma membrane; comes from damaged or aged cells that have been taken up by macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How can an enzyme deficiency shift metabolism?

A
  • Depletion of downstream metabolites

- Upregulation of minor pathways to consume metabolite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the appearance of a Gaucher’s lysosome.

A

Buildup of glucosylceramide in macrophages gives macrophage containing lysosomes a “crepe paper” appearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What cells and tissues are effected by Gaucher’s?

A

Abnormal macrophages accumulate in various organs:

  • Bone marrow: monocytes are macrophage precursors
  • Liver: Kupffer cells
  • Bone: osteoclasts and osteoblasts
  • Lung: alveolar macrophages (less significant)
  • Spleen: tissue macrophages
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the symptoms of Gaucher’s disease?

A
  • Hepatomegaly
  • Splenomegaly = enlarged spleen becomes overactive and begins removing healthy RBCs, platelets, etc.
  • Thrombocytopenia = low platelet count causing easy bruising and excess bleeding
  • Anemia = low RBCs
  • Leukopenia = low WBCs
  • Bone disease = Erlenmeyer flask deformity (convex instead of concave bones), avascular necrosis (bone death)
  • Bone pain = chronic aching + acute excruciating pain lasting days to weeks and requiring opioid analgesics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the prevalence of Type I Gaucher’s disease?

A
  • Most common type of types I-III Gaucher’s
  • 1 in 40,000-60,000 in general populaiton
  • 1 in 500 Ashkenazi Jews
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the genetic pattern of transmission of Gaucher’s disease?

A

Autosomal recessive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

When is Gaucher’s usually diagnosed?

A

~ 50% of cases by age 10 with ~2/3 by age 20

Varied severity of disease can lead to delayed recognition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the childhood symptoms of Gaucher’s and how does the disease progress?

A
  • Growth retardation after first 1-2 years of life
  • Delayed puberty
  • Progressive disease: glucocerebroside continues to accumulate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the treatment for Gaucher’s and how effective is it?

A
  • Enzyme replacement therapy was introduced in 1991; prior there were only symptomatic treatments
  • Recombinant human enzyme (imiglucerase) is given every other week by IV
  • $400,000+ annual price tag
  • Dramatic improvement of hemoglobin, platelets, liver/spleen volume, bone pain, and bone crisis in first 6-12 mo followed by plateau/slight improvement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the purpose of the Orphan Drug Act?

A
  • Provide an incentive for pharma to invest in drug development for rare diseases as it can cost $500mil-$1bil to bring a drug to market but rare diseases have a small market.
  • Incentives include marketing exclusivity, grants and tax credits for clinical trials, and FDA fee exemptions.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the definition of a rare disease?

A

Affecting < 200,000 in the US

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can conflicts of interest arise with rare disease treatment?

A
  • Pharma wants to cultivate physicians who are interested in treating the disease so the drug will have more market
  • Pharma offers copay assistance to encourage more patients to use the drug